# PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

> **NCT00132938** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 5660 (—)

## Conditions studied

- Chronic Bronchitis

## Interventions

- **DRUG:** telithromycin

## Key facts

- **NCT ID:** NCT00132938
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 5660 (—)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132938, "PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00132938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*